 AUSTIN, Texas, March 01, 2022 GLOBE NEWSWIRE -- Molecular Templates, Inc. Nasdaq: MTEM, Molecular Templates or MTEM, a clinical-stage biopharmaceutical company focused on the discovery and development of the companys proprietary engineered toxin bodies ETBs, which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, will participate in several upcoming investor conferences. 